Electronic Identification and Trust Services for Electronic... · SCHEDULE 3

10 National Health Service (Pharmaceutical Services) (Wales) Regulations 2013

Sch. 3 para. 10 · in force: yes

Captured statutory text (L5)

10 National Health Service (Pharmaceutical Services) (Wales) Regulations 2013

In the National Health Service (Pharmaceutical Service) (Wales) Regulations 2013 —

(a)in the English language text, in regulation 2(1) (interpretation), for the definition “advanced electronic signature”, substitute— “advanced electronic signature” means an advanced electronic signature as defined in Article 3(11) of Regulation (EU) No 910/2014 of the European Parliament and of the Council on electronic identification and trust services for electronic transactions in the internal market; ; and

(b)in the Welsh language text, in regulation 2(1) (Dehongli), for the definition “llofnod electronig uwch”, substitute— ystyr “llofnod electronig uwch” yw llofnod electronic uwch fel y'i diffinir yn Erthygl 3(11) o Reoliad (EU) Rhif 910/2014 Senedd Ewrop a'r Cyngor ar adnabod electronig a gwasanaethau ymddiried ar gyfer trafodiadau electronig yn y farchnad fewnol; .

Full captured verbatim text

In the National Health Service (Pharmaceutical Service) (Wales) Regulations 2013 —

(a) in the English language text, in regulation 2(1) (interpretation), for the definition “advanced electronic signature”, substitute—

“advanced electronic signature” means an advanced electronic signature as defined in Article 3(11) of Regulation (EU) No 910/2014 of the European Parliament and of the Council on electronic identification and trust services for electronic transactions in the internal market;

; and

(b) in the Welsh language text, in regulation 2(1) (Dehongli), for the definition “llofnod electronig uwch”, substitute—

ystyr “llofnod electronig uwch” yw llofnod electronic uwch fel y'i diffinir yn Erthygl 3(11) o Reoliad (EU) Rhif 910/2014 Senedd Ewrop a'r Cyngor ar adnabod electronig a gwasanaethau ymddiried ar gyfer trafodiadau electronig yn y farchnad fewnol;

.

What this provision means

Model summary, checked against the text on the left.

Relevance to Signicat: 2/3 · detailed summary (L4) Status: not needed for a short provision · Stored artifact; current recipe verification unavailable

Advanced electronic signature in Welsh pharmaceutical services regulations is defined in English and Welsh by reference to Regulation EU No 910/2014.

Only the one-line summary above is stored for this provision; the text itself is the evidence.

Refers to

cross-reference internal_cite · reg. 2

Referred to by

schedule ref schedule_ref · reg. 5

Part summaries

0 of 0 parts have a verified summary.

L1 unavailable for current verification: the overall summary needs every part verified. Provisions and the verified summaries remain readable.

Verification findings (75)

synthesis coverage: missing/unverified L2 part-1

synthesis coverage: missing evaluation uk:uksi/2016/696#regulation-1

synthesis coverage: missing evaluation uk:uksi/2016/696#regulation-2

synthesis coverage: missing/unverified L2 part-2

synthesis coverage: missing evaluation uk:uksi/2016/696#regulation-3

synthesis coverage: missing/unverified L2 part-3

synthesis coverage: missing evaluation uk:uksi/2016/696#regulation-4

synthesis coverage: missing evaluation uk:uksi/2016/696#regulation-5

synthesis coverage: missing evaluation uk:uksi/2016/696#regulation-6

synthesis coverage: missing/unverified L2 schedule-1

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-1-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-1-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-1-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-1-paragraph-4

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-1-paragraph-5

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-1-paragraph-6

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-1-paragraph-7

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-1-paragraph-8

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-1-paragraph-9

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-1-paragraph-10

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-1-paragraph-11

synthesis coverage: missing/unverified L2 schedule-2

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-4

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-5

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-6

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-6A

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-7

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-7A

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-7B

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-8

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-9

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-10

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-11

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-12

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-13

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-14

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-15

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-16

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-17

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-18

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-19

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-20

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-21

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-22

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-23

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-24

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-25

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-26

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-27

synthesis coverage: missing/unverified L2 schedule-3

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-3-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-3-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-3-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-3-paragraph-4

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-3-paragraph-5

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-3-paragraph-6

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-3-paragraph-7

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-3-paragraph-8

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-3-paragraph-9

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-3-paragraph-10

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-3-paragraph-11

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-3-paragraph-12

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-3-paragraph-13

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-3-paragraph-14

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-3-paragraph-15

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-3-paragraph-16

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-3-paragraph-17

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-3-paragraph-18

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-3-paragraph-19

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-3-paragraph-20

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-3-paragraph-21

Instrument tier unavailable

Change history as published

Sch. 3 para. 7 revoked (24.2.2025) by The Procurement Act 2023 (Consequential and Other Amendments) Regulations 2025 (S.I. 2025/163), reg. 1(2), Sch. Pt. 2

Sch. 3 para. 17 revoked (24.2.2025) by The Procurement Act 2023 (Consequential and Other Amendments) Regulations 2025 (S.I. 2025/163), reg. 1(2), Sch. Pt. 2

Sch. 3 para. 20 revoked (24.2.2025) by The Procurement Act 2023 (Consequential and Other Amendments) Regulations 2025 (S.I. 2025/163), reg. 1(2), Sch. Pt. 2

Pending effects amendments not yet applied to this text

No captured pending effects.

Provenance

Every claim the system makes about this text is traceable to these identifiers.

Instrument: uk:uksi/2016/696
Part: SCHEDULE 3
Version: d49dbc556a03966e92c4becd…
Content hash: sha256 9d157dea5955bf5ea3440499…
Source: legislation.gov.uk/uksi/2016/696